ALKBH5 Regulates Corneal Neovascularization by Mediating FOXM1 M6A Demethylation
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.12.34 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Wei Wang and 6 co-authors. Institution: Department of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Major MEDLINE topics: AlkB Homolog 5, RNA Demethylase, Corneal Neovascularization, Demethylation, Disease Models, Animal. Cited 9 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
This study aims to explore the regulatory role and potential mechanisms of ALKBH5-mediated N6-methyladenosine (m6A) demethylation modification in corneal neovascularization (CNV).
Methods
A mouse CNV model was established through corneal alkali burns. Total m6A levels were measured using an m6A RNA methylation quantification kit. The mRNA expression of candidate m6A-related enzymes was quantified by quantitative RT-PCR. Small interfering RNA targeting ALKBH5 was injected subconjunctivally into alkali-burned mice. The CNV area, corneal epithelial thickness, and pathological changes were evaluated. Protein expression was detected by western blot and immunofluorescence. Human umbilical vein endothelial cells (HUVECs) were treated with IL-6. Plasmid transfection knocked down ALKBH5 or overexpressed FOXM1 in IL-6-induced HUVECs. The assays of CCK8, wound healing, and tube formation evaluated the cell proliferation, migration, and tube formation abilities, respectively. The dual-luciferase assay examined the binding between ALKBH5 and FOXM1. Methylated RNA immunoprecipitation-qPCR detected the m6A levels of FOXM1.
Results
Significant CNV was observed on the seventh day. Total m6A levels were reduced, and ALKBH5 expression was increased in CNV corneas and IL-6-induced HUVECs. ALKBH5 knockdown alleviated corneal neovascularization and inflammation and countered IL-6-induced promotion of cell proliferation, migration, and tube formation in HUVECs. ALKBH5 depletion increased m6A levels and decreased VEGFA and CD31 expression both in vivo and in vitro. This knockdown in HUVECs elevated m6A levels on FOXM1 mRNA while reducing its mRNA and protein expression. Notably, FOXM1 overexpression can reverse ALKBH5 depletion effects.
Conclusions
ALKBH5 modulates FOXM1 m6A demethylation, influencing CNV progression and highlighting its potential as a therapeutic target.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Pathology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Cite
APA
Wang, W., Li, H., Qian, Y., Li, M., Deng, M., Bi, D., & Zou, J. (2024). ALKBH5 Regulates Corneal Neovascularization by Mediating FOXM1 M6A Demethylation. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.12.34
Vancouver
Wang W, Li H, Qian Y, Li M, Deng M, Bi D, et al. ALKBH5 Regulates Corneal Neovascularization by Mediating FOXM1 M6A Demethylation. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.12.34
BibTeX
@article{Wang2024,
author = {Wang, Wei and Li, Hua and Qian, Yiyong and Li, Min and Deng, Manli and Bi, Dexi and Zou, Jun},
title = {ALKBH5 Regulates Corneal Neovascularization by Mediating FOXM1 M6A Demethylation},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.12.34}
}
EUVIMED